切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (01) : 68 -71. doi: 10.3877/cma.j.issn.2095-3232.2024.01.013

临床研究

ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用
沈佳佳, 何经雄, 王芳, 江艺, 潘凡, 张小进()   
  1. 350025 福州,第九〇〇医院肝胆外科
    350025 福州,福建医科大学福总临床医学院
  • 收稿日期:2023-11-06 出版日期:2024-02-10
  • 通信作者: 张小进
  • 基金资助:
    福建省自然基金项目(2020J011136); 福建省引导性项目(2020Y0078); 联勤保障部队第九〇〇医院院内课题(2021ZD06)

Application of ICG fluorescence-guided laparoscopic radiofrequency ablation for patients with small liver cancer complicated with severe macronodular cirrhosis

Jiajia Shen, Jingxiong He, Fang Wang, Yi Jiang, Fan Pan, Xiaojin Zhang()   

  1. Department of Hepatobiliary Surgery, The 900th Hospital, Fuzhou 350025, China
    School of Clinical Medicine, Fuzhou General Hospital, Fujian Medical University, Fuzhou 350025, China
  • Received:2023-11-06 Published:2024-02-10
  • Corresponding author: Xiaojin Zhang
引用本文:

沈佳佳, 何经雄, 王芳, 江艺, 潘凡, 张小进. ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 68-71.

Jiajia Shen, Jingxiong He, Fang Wang, Yi Jiang, Fan Pan, Xiaojin Zhang. Application of ICG fluorescence-guided laparoscopic radiofrequency ablation for patients with small liver cancer complicated with severe macronodular cirrhosis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(01): 68-71.

目的

探讨ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用价值。

方法

回顾性分析2021年12月至2022年6月在第九〇〇医院应用ICG荧光引导腹腔镜射频消融治疗的14例合并严重大结节肝硬化小肝癌患者临床资料。其中男13例,女1例;年龄45~82岁,中位年龄65岁。患者均签署知情同意书,符合医学伦理学规定。肿瘤均位于近肝被膜下,病灶直径0.8~3.0 cm。患者术前注射ICG,行术中荧光腹腔镜探查、肿瘤定位后再行射频消融,观察消融效果及术后恢复情况。

结果

14例均为术中肉眼难以鉴别的肿瘤与硬化结节,其中13例在多模荧光和标准荧光下能清晰鉴别肿瘤位置、边界,并顺利完成射频消融。1例术中见全肝荧光染色,无法鉴别,联合术中超声定位肿瘤后完成射频消融。14例患者术后恢复顺利,均无并发症发生,中位住院时间13 d。术后1个月复查MRI,均达到肿瘤完全消融。

结论

对于肝被膜下合并严重大结节肝硬化小肝癌患者,ICG荧光引导腹腔镜射频消融具有可靠的定位和定性诊断价值方法,是可行、有效的治疗手段。

Objective

To evaluate the application value of ICG fluorescence-guided laparoscopic radiofrequency ablation in the treatment of small liver cancer complicated with severe macronodular cirrhosis.

Methods

Clinical data of 14 small liver cancer patients complicated with severe macronodular cirrhosis treated with ICG fluorescence-guided laparoscopic radiofrequency ablation in the 900th Hospital from December 2021 to June 2022 were retrospectively analyzed. Among them, 13 patients were male and 1 female, aged from 45 to 82 years, with a median age of 65 years. The informed consents of all patients were obtained and the local ethical committee approval was received. All tumors were located adjacent to the liver capsule, and the lesion size was ranged from 0.8 to 3.0 cm in diameter. All patients were injected with ICG before surgery, received intraoperative fluorescence-guided laparoscopic exploration and tumor localization, and then underwent radiofrequency ablation. The ablation effect and postoperative recovery were observed.

Results

All 14 patients were diagnosed with indistinguishable tumors and cirrhotic nodules intraoperatively. Among them, tumor location and margin could be clearly identified under multimode and standard fluorescence in 13 cases, and they successfully completed radiofrequency ablation. Intraoperatively, fluorescence staining of the whole liver was found in 1 case, which could not be identified. Radiofrequency ablation was performed after intraoperative ultrasound localization of the tumor. 14 patients were properly recovered without complications. The median length of hospital stay was 13 d. MRI at 1 month after surgery showed that complete tumor ablation was achieved in all cases.

Conclusions

ICG fluorescence-guided laparoscopic radiofrequency ablation is a feasible and efficacy for small liver cancer patients complicated with severe macronodular cirrhosis, which yields reliable localization and qualitative diagnostic value.

图1 一例行ICG荧光导航腹腔镜射频消融术的合并严重大结节肝硬化小肝癌患者术中注:术中全肝呈荧光染色,肿瘤位置显示不清,联合术中超声完成射频治疗
图2 一例小肝癌合并严重大结节型肝硬化患者行ICG荧光导航腹腔镜射频消融术注:a示术中普通模式探查肝脏呈严重大结节型肝硬化,肉眼难以鉴别硬化结节与肿瘤;b示多模荧光与标准荧光下清晰显示肝Ⅶ、Ⅷ段肿块;c为直视下沿肿瘤按"品"字型位置消融3针,肿瘤达到完全消融
[1]
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158.
[2]
郑文杰, 田虎. 腹腔镜超声引导下射频消融治疗原发性小肝癌的疗效分析[J]. 腹腔镜外科杂志, 2020, 25(12):925-927, 931.
[3]
陈亚峰, 李江斌, 钟文钧, 等. 腹腔镜微波消融治疗≤3 cm肝细胞肝癌的临床疗效分析[J/OL]. 中华腔镜外科杂志(电子版), 2021, 14(5):271-276.
[4]
周善学, 陈云杰, 尹小斌, 等. 腹腔镜射频消融术与腹腔镜肝切除术治疗小肝癌的疗效对比研究[J]. 腹腔镜外科杂志, 2019, 24(4):258-262.
[5]
彭沙沙, 郭浚, 夏国兵, 等. 特殊或高危部位原发性小肝癌超声引导下腹腔镜射频消融术治疗效果及术后免疫状况分析[J]. 中华解剖与临床杂志, 2019, 24(5):458-463.
[6]
鲁葆春, 杨建辉, 唐海军, 等. 吲哚菁绿荧光实时成像联合术中超声技术在特殊部位腹腔镜肝癌切除术中的应用[J]. 肝胆胰外科杂志, 2021, 33(3):170-172, 177.
[7]
方驰华, 王晓颍, 刘允怡. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中应用指南(2019版)[J]. 中国实用外科杂志, 2019, 39(7):641-650, 654.
[8]
刘永昌, 赵殿堂, 孙启峰, 等. 吲哚菁绿荧光导航和三维可视化腹腔镜精准手术治疗原发性肝癌患者应用研究[J]. 实用肝脏病杂志, 2021, 24(4):561-564.
[9]
谢国伟, 李嘉鑫, 吴泓. 吲哚氰绿荧光显像导航技术在复发性肝癌腹腔镜再次肝切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(2):153-157.
[10]
Hsiao CY, Hu RH, Ho CM, et al. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study[J]. Am J Surg, 2020, 220(4):958-964.
[11]
Feng H, Yang C, Xu F, et al. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching analysis[J]. Eur J Surg Oncol, 2022, 48(2):418-424.
[12]
张发鹏, 袁荣发, 张引, 等. 腹腔镜下射频消融治疗小肝癌的临床疗效分析[J]. 中国普通外科杂志, 2018, 27(1):35-41.
[13]
邱泽成, 陈斌, 李柳生, 等. 超声引导下经皮射频消融与腹腔镜肝切除术治疗直径≤3 cm原发性肝癌的疗效分析[J]. 中国现代普通外科进展, 2019, 22(9):708-710.
[14]
徐娟, 李俊芝, 房勤茂. 超声造影联合实验室指标诊断早期肝硬化结节状小肝癌的价值[J]. 临床超声医学杂志, 2021, 23(9):698-701.
[15]
李晋, 何志唯, 陈志雄. 彩超声像图色阶在鉴别小肝癌癌结节和肝硬化假小叶结节中的价值[J]. 临床医学研究与实践, 2021, 6(31):119-121
[16]
罗建平. 探究肝硬化结节与微小肝癌应用彩超诊断与鉴别的效果[J]. 影像研究与医学应用, 2019, 3(3):24-25.
[17]
尚兴国, 张雪棉, 岳秀杰, 等. 纳米炭与吲哚箐绿荧光两种示踪法对甲状腺微小乳头状癌术中淋巴结清扫和甲状旁腺保护作用研究[J]. 标记免疫分析与临床, 2020, 27(3):423-427.
[18]
张中林, 李晓勉, 李锟, 等. 吲哚菁绿荧光成像在腹腔镜肝脏外科手术中的应用[J].中华肝胆外科杂志, 2019, 25(2):81-86.
[19]
中华医学会数字医学分会, 中国研究型医院学会数字医学临床外科专业委员会, 中国图学学会医学图像与设备专业委员会, 等. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中的应用专家共识[J]. 中国实用外科杂志, 2017, 37(5):531-538.
[20]
唐啸, 岳志强, 蔡卫华, 等. ICG荧光融合影像技术在肝癌腹腔镜解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(1):39-43.
[21]
何攀, 苏松, 方程, 等. 吲哚菁绿荧光成像在开腹肝癌切除术中的应用分析[J]. 中华肝胆外科杂志, 2019, 25(11):809-811.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[4] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[5] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[6] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[7] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[8] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[9] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[10] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[11] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[12] 李腾成, 黄群雄, 胡成, 肖恒军, 徐锦斌, 高舜天, 黄展森, 高新, 狄金明. 机器人腹腔镜后入路筋膜内和筋膜外根治性前列腺切除术技术分析[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 12-18.
[13] 任磊, 张瑞敏, 赵永祥. 隐睾患儿病因分析及临床诊疗进展[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 100-104.
[14] 马楠, 杨振宇, 林旭曼, 刘振华, 陈贤达, 郭胜杰, 韩辉, 周芳坚, 刘卓炜, 尧凯. 免气腹单孔后腹腔镜肾上腺肿瘤切除术初步探讨[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 25-30.
[15] 张传海, 周毅, 王一帆, 马金良. 基于"红/黄交界线"胆囊板入路联合ICG荧光导航的腹腔镜解剖性肝切除(附视频)[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 62-67.
阅读次数
全文


摘要